Del Senno L, Degli Uberti E, Rossi M, Buzzoni D, Barbieri R, Rossi P, Patracchini P, Bernardi F, Marchetti G, Conconi F
FEBS Lett. 1986 Feb 17;196(2):296-300. doi: 10.1016/0014-5793(86)80266-6.
In this paper we describe an alteration of the c-myc oncogene present in the white blood cells and normal as well as neoplastic thyroid cells of a subject carrying a thyroid carcinoma. Restriction enzyme mapping and hybridization to human c-myc probes specific for different regions of this gene demonstrate that this subject carries, in addition to the normal one, a c-myc oncogene lacking the first exon and part of the first intron. The levels of the c-myc mRNA in thyroid cells of this subject do not show differences with respect to thyroid cells from other subjects. Taken together, these findings indicate that the deletion of the first exon of the c-myc oncogene, in itself, does not produce overtranscription of this oncogene nor hematopoietic malignancies.
在本文中,我们描述了一名患有甲状腺癌的受试者的白细胞、正常甲状腺细胞及肿瘤性甲状腺细胞中存在的c-myc癌基因的一种改变。限制性内切酶图谱分析以及与针对该基因不同区域的人c-myc探针杂交表明,该受试者除了正常的c-myc癌基因外,还携带一个缺少第一外显子和部分第一内含子的c-myc癌基因。该受试者甲状腺细胞中c-myc mRNA的水平与其他受试者的甲状腺细胞相比没有差异。综上所述,这些发现表明,c-myc癌基因第一外显子的缺失本身不会导致该癌基因的过度转录,也不会引发造血系统恶性肿瘤。